Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples